Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Intussusception Market, by Type
6.1 Introduction
6.2 Ileoileal
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Ileocolic
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Ileo-Ileo-Colic
6.4.1 Market Estimates & Forecast, 2020-2027
6.5 Others
6.5.1 Market Estimates & Forecast, 2020-2027
7. Global Intussusception Market, by Diagnosis
7.1 Introduction
7.2 Barium Enema
7.2.1 Market Estimates & Forecast, 2020-2027
7.3 Ultrasound
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 X-Ray
7.4.1 Market Estimates & Forecast, 2020-2027
7.5 Computerized Tomography (Ct)
7.5.1 Market Estimates & Forecast, 2020-2027
7.6 Other
7.6.1 Market Estimates & Forecast, 2020-2027
8. Global Intussusception Market, by Treatment
8.1 Introduction
8.2 Surgery
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Drugs
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Others
8.4.1 Market Estimates & Forecast, 2020-2027
9. Global Intussusception Market, by End User
9.1 Introduction
9.2 Hospitals & Clinics
9.2.1 Market Estimates & Forecast, 2020-2027
9.3 Academic and Research Institutes
9.3.1 Market Estimates & Forecast, 2020-2027
9.4 Others
9.4.1 Market Estimates & Forecast, 2020-2027
10. Global Intussusception Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 UK
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Novartis AG
12.1.1 Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 Key Developments
12.2 Janssen Pharmaceuticals
12.2.1 Overview
12.2.2 Product Overview
12.2.3 Financials
12.2.4 Key Developments
12.3 Carestream Health
12.3.1 Overview
12.3.2 Product Overview
12.3.3 Financials
12.3.4 Key Development
12.4 Pfizer Inc.
12.4.1 Overview
12.4.2 Product Overview
12.4.3 Financials
12.4.3 Key Development
12.5 Shimadzu Corporation
12.5.1 Overview
12.5.2 Product Overview
12.5.3 Financials
12.5.4 Key Development
12.6 Ranbaxy Laboratories Limited
12.6.1 Overview
12.6.2 Product Overview
12.6.3 Financials
12.6.4 Key Development
12.7 Bristol Myers Squibb Company
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Development
12.8 Fujifilm Holdings
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Development
12.9 GlaxoSmithKline Plc.
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Development
12.10 Others
12.10.1 Overview
12.10.2 Product Overview
12.10.3 Financials
12.10.4 Key Development
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Intussusception Treatment Industry
14 Appendix
List of Tables
TABLE 1 GLOBAL INTUSSUSCEPTION MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 2 PHYSICAL EXAMINATION FOR INTUSSUSCEPTION MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 3 PSEUDOMEMBRANOUS FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD
MILLION)
TABLE 4 ERYTHEMATOUS FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD
MILLION)
TABLE 5 HYPERPLASTIC FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 6 OTHERS FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 7 GLOBAL INTUSSUSCEPTION MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION)
TABLE 8 EXAMINATION FOR INTUSSUSCEPTION MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 9 BIOPSY FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 10 ENDOSCOPY FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 11 OTHERS FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 12 GLOBAL INTUSSUSCEPTION MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 13 ANTI-FUNGAL FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 14 IMMUNE-MODULATORS FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD
MILLION)
TABLE 15 OTHERS FOR INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 16 GLOBAL INTUSSUSCEPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 17 NORTH AMERICA INTUSSUSCEPTION MARKET, BY COUNTRY 2020-2027 (USD MILLION)
TABLE 18 NORTH AMERICA INTUSSUSCEPTION MARKET, BY TYPE 2020-2027 (USD MILLION)
TABLE 19 NORTH AMERICA INTUSSUSCEPTION MARKET, BY DIAGNOSIS 2020-2027 (USD MILLION)
TABLE 20 NORTH AMERICA INTUSSUSCEPTION MARKET, BY TREATMENT 2020-2027 (USD
MILLION)
TABLE 21 NORTH AMERICA INTUSSUSCEPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 22 NORTH AMERICA INTUSSUSCEPTION MARKET BY REGION 2020-2027 (USD MILLION
TABLE 23 EUROPE INTUSSUSCEPTION MARKET BY COUNTRY 2020-2027 (USD MILLION)
TABLE 24 EUROPE INTUSSUSCEPTION MARKET, BY TYPE 2020-2027 (USD MILLION)
TABLE 25 EUROPE INTUSSUSCEPTION MARKET, BY DIAGNOSIS 2020-2027 (USD MILLION)
TABLE 26 EUROPE INTUSSUSCEPTION MARKET, BY TREATMENT 2020-2027 (USD MILLION)
TABLE 27 EUROPE INTUSSUSCEPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 28 EUROPE INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 29 ASIA PACIFIC INTUSSUSCEPTION MARKET BY COUNTRY 2020-2027 (USD MILLION)
TABLE 30 ASIA PACIFIC INTUSSUSCEPTION MARKET, BY TYPE 2020-2027 (USD MILLION)
TABLE 31 ASIA PACIFIC INTUSSUSCEPTION MARKET, BY DIAGNOSIS 2020-2027 (USD MILLION)
TABLE 32 ASIA PACIFIC INTUSSUSCEPTION MARKET, BY TREATMENT 2020-2027 (USD MILLION)
TABLE 33 ASIA PACIFIC INTUSSUSCEPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 34 ASIA PACIFIC INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET BY COUNTRY 2020-2027 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET, BY TYPE 2020-2027 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET, BY DIAGNOSIS 2020-2027 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET, BY TREATMENT 2020-2027 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET, BY REGION 2020-2027 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET DYNAMICS FOR GLOBAL INTUSSUSCEPTION MARKET
FIGURE 3 GLOBAL INTUSSUSCEPTION MAKRET, BY SEGMENT, 2020
FIGURE 4 GLOBAL INTUSSUSCEPTION SUCCESS MARKET, BY REGION
FIGURE 5 GLOBAL INTUSSUSCEPTION MARKET SHARE, BY TYPE 2020
FIGURE 6 GLOBAL INTUSSUSCEPTION MARKET SHARE, BY DIAGNOSIS 2020
FIGURE 7 GLOBAL INTUSSUSCEPTION MARKET SHARE, BY TREATMENT, 2020
FIGURE 8 GLOBAL INTUSSUSCEPTION MARKET SHARE, BY END USER, 2020
FIGURE 9 GLOBAL INTUSSUSCEPTION MARKET SHARE, 2020
FIGURE 10 GLOBAL INTUSSUSCEPTION MARKET SHARE, BY REGION, 2020
FIGURE 11 NORTH AMERICA INTUSSUSCEPTION MARKET SHARE, BY COUNTRY, 2020
FIGURE 12 EUROPE INTUSSUSCEPTION MARKET SHARE, BY COUNTRY, 2020
FIGURE 13 ASIA PACIFIC INTUSSUSCEPTION MARKET SHARE, BY COUNTRY, 2020
FIGURE 14 MIDDLE EAST & AFRICA INTUSSUSCEPTION MARKET, BY REGION, 2020
FIGURE 15 GLOBAL INTUSSUSCEPTION MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 16 PFIZER INC.: KEY FINANCIALS
FIGURE 17 PFIZER INC.: SEGMENTAL REVENUE
FIGURE 18 PFIZER INC.: GEOGRAPHICAL REVENUE
FIGURE 19 CARESTREAM HEALTH: KEY FINANCIALS
FIGURE 20 CARESTREAM HEALTH: SEGMENTAL REVENUE
FIGURE 21 CARESTREAM HEALTH: GEOGRAPHICAL REVENUE
FIGURE 22 FUJIFILM HOLDINGS: KEY FINANCIALS
FIGURE 23 FUJIFILM HOLDINGS: SEGMENTAL REVENUE
FIGURE 24 FUJIFILM HOLDINGS: GEOGRAPHICAL REVENUE
FIGURE 25 SHIMADZU CORPORATION: KEY FINANCIALS
FIGURE 26 SHIMADZU CORPORATION: SEGMENTAL REVENUE
FIGURE 27 SHIMADZU CORPORATION: GEOGRAPHICAL REVENUE
FIGURE 28 GLAXOSMITHKLINE: FINANCIAL REVENUE
FIGURE 29 GLAXOSMITHKLINE: SEGMENTAL REVENUE
FIGURE 30 GLAXOSMITHKLINE: GEOGRPAHICAL REVENUE
FIGURE 31 NOVARTIS AG: FINANCIAL REVENUE
FIGURE 32 NOVARTIS AG: SEGMENTAL REVENUE
FIGURE 33 NOVARTIS AG: GEOGRPAHICAL REVENUE